We conducted a retrospective study of 86 patients with systemic sclerosis (SSc) to clarify the initial predictors of survival at the first visit to the hospital. A life-table analysis of survival was performed concerning 137 items from their histories, physical examinations, and laboratory data. The observed cumulative survival rates were 78.0 percent at 5 years and 68.2 percent at 10 years. Ten items were found to be the initial predictors of survival in patients with SSc. Of these 10 items, 9 items showed significant differences within 5 years of the first visit to the hospital. Patients with resting electrocardiographic abnor malities, such as atrial or ventricular arrhythmias, or conduction disturbances, pulmonary fibrosis on the chest x-ray films, or decreased vital capacity had significantly lower survival rates. However, patients with anti-centromere antibody had a significantly better survival rate. In addition, males, aged patients over 65
Introduction
Systemic sclerosis (SSc: scleroderma) is a systemic con nective tissue disease characterized by fibrotic and de generative changes in the skin and vascular changes, and is accompanied by serious internal organ involvement.1,2 Clinical severity and progression vary among subsets ranging from limited scleroderma to diffuse scleroderma, according to the extent of skin involvement. However, patients often have different degrees of visceral involve ment and different prognoses even when classified in the same subset. 3 Many retrospective studies on survival in SSc patients have been performed. is Clinical manifestations and laboratory data during the entire observation period were analyzed in these studies. Although it is generally accepted that cardiopulmonary and renal involvements have been the main causes of decreased survival, the initial predictors in patients with SSc at the first visit to the hospital are not clear. In this study, clinical and laboratory data at the first visit to the hospital were analyzed to clarify the initial predictors of survival in Japanese patients with SSc.
Patients and Methods

Patients
Eighty-six patients with SSc at Keio University Hospi tal, Department of Internal Medicine, were studied. These patients were diagnosed with SSc according to the preliminary criteria for the classification of SSc of the American Rheumatism Association (American College of Rheumatology). 16 Five patients with complete CREST syndrome were included. However, they were not defi nitely diagnosed as overlap syndrome with systemic lupus erythematosus, polymyositis or dermatomyositis . 
Patient profiles
Of the 86 patients with SSc studied, 75 were women and 11 were men. All patients were Japanese. The mean age of the patients at the first visit to the hospital was 47.5 years (range, 19 to 76). Six patients over 65 years old were regarded as the aged. The mean observation period was 5.1 years (range, 0 to 15). During the obser vation period, 46 patients survived, while 25 patients died and 15 patients were lost to follow-up.
Overall survivorship
The observed cumulative survival rates were 78.0 percent at 5 years and 68.2 percent at 10 years (Fig 1) . 
